Log In      Register Advertisement
Managed Care

Comprehensiveness of Care Cuts Cost

MANAGED CARE July 2015. © MediMedia USA
News & Commentary

Comprehensiveness of Care Cuts Cost

Medicare beneficiaries with primary care physicians (PCPs) who are less likely to refer them to specialists (that is, the PCPs provide more comprehensive care) are 35% less likely to be hospitalized, according to a study published in the Annals of Family Medicine.

The issue is: What difference does it make when patients see PCPs who offer more comprehensive care, as defined by the American Board of Family Medicine?

Answer: A lot. Costs for patients offered more comprehensive primary care were 10% to 13% less. “Increasing family physician comprehensiveness of care, especially as measured by claims measures, is associated with decreasing Medicare costs and hospitalizations,” the study states.

Comprehensive care varied greatly, depending on the procedure. For instance, 63% of PCPs cared for newborns while, at the other end of the scale, 2% performed major surgery. Other activities included minor office surgery (61.4%), pain management (46.4%), and palliative care (25.9%).

Researchers with the Robert Graham Center in Washington analyzed claims data from about 3,600 family physicians that contain information about hospitalizations and total costs for about 555,000 Medicare beneficiaries.

Traditionally, primary care services have encompassed care for all kinds of patients and medical problems and has included inpatient and outpatient care, obstetrics, pediatrics, geriatrics, and even minor surgery. The challenge of providing this kind of all-comers care can be daunting, requiring primary care physicians to work in multiple settings and deal with the increasing complexity of chronic care.

But the general scope of care provided by family physicians has been shrinking, the Graham Center authors note. At the same time, they add, “family physicians are being asked to acquire and employ new skills in greater population health management, administration and leadership teams, and informatics—all this while caring for an aging and increasingly multimorbid pool of patients.”

MC TV

Explore the complexities of the biosimilars’ landscape, such as naming, interchangeability and substitution, differences in the manufacturing processes, as well as the approval pathways & FDA guidelines for biologics, including draft guidance on biosimilars.

USA-BIO-106112

News & Commentary
Finally, a success story for the struggling health insurance exchange (HIE) effort. Researchers were able to accurately predict health care utilization in Maine for more than a million patients for six months using only demographic and electronic medical records (EMRs) data from the previous year.
News & Commentary
Emergency surgeries for ulcerative colitis and Crohn’s disease are often performed by less experienced physicians and can occur during off-hours and weekends, when there’s fewer people working, says a meta-analysis in Gastroenterology. The lower risk of elective surgery may in part be explained by the greater use of laparoscopic surgery.
Medication Management
Thomas Reinke
Cardinal Health and McKesson see a future in an idea that has had difficulty taking root. They’re betting that MTM and adherence services will become more important as CMS expands its requirements for comprehensive medication reviews in 2016 and as accountable care programs use adherence as a tool to control costs.
News & Commentary
The American College of Physicians likes retail clinics just fine, so long as they are used as backups to the work of primary care physicians, according an ACP position paper in the Annals of Internal Medicine. They are not really equipped to handle chronic conditions, either. The organization representing retail clinics says that most of its members follow these guidelines.
Biologics In Development
Katherine T. Adams
Several commentators at the 2015 European Cancer Congress noted that as good as this and other new immunotherapy drugs may be, they are very costly—and in Europe, several countries with socialized medicine programs will not be able to afford them.
Managed Care Outlook
Reaching benchmarks for risk factor reduction could reduce premature deaths worldwide to 5.7 million in 2025. Those risk factor targets are a 30% decrease in tobacco smoking, a 25% reduction in prevalence of hypertension, no increase in the number of people with diabetes, and no increase in the number of people who are obese.
Tomorrow’s Medicine
Thomas Morrow, MD
A stent called Synergy is the first stent approved in this country as a treatment of coronary artery disease that’s made with a bioresorbable polymer coating. The polymer effectively disappears, leaving behind only the biologically inert bare-metal stent that the body covers with a fresh layer of endothelial tissue.
Original Research
Abhishek Chitnis, MPharm, PhD
Shawn X. Sun, PhD
Shailja Dixit, MD, MPH
Rosa Wang, MHA
The medication did this mostly by reducing the level of inpatient care for over 350 patients in the six months immediately following initiation. Researchers suggest that further studies should confirm this conclusion and also investigate just how long these reductions can be sustained.
Feature
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Hospitalists are still concerned with individual patients, but they are now becoming managers of population health, forcing hospitals to shift their attention from decreasing length of stay (LOS) and preventing payer denials to decreasing hospitalizations. This significantly benefits both payers and patients.